Skip to main content

Table 1 representative results of detoxification studies

From: In vivo administration of BL-3050: highly stable engineered PON1-HDL complexes

Time prior CPO induction

Group1

Score

Mortality

(%)

Severe reaction

(%)

 

untreated2

3.6

62.5

37.5

 

TBS

3.8

75

25

 

POPC

3.9

87.5

12.5

5 min

    
 

Atropine+2PAM3

0.5*

0

0

 

BL-30504

1.3*

12.5

0

3 hours

    
 

Atropine+2PAM3

2.1

25

12.5

 

BL-30504

1.3*

12.5

0

 

rePON1-TBS4

1.4*

12.5

12.5

14 hours

    
 

BL-30504

3.0

50

25

 

rePON1-TBS4

1.8*

0

12.5

 

rePON1-TBS5

1.1*

12.5

12.5

  1. Single oral gavage of CPO (23 mg/kg, 10 mL/kg dose) to male C57BL/6J mice was preceded (5 min, 3 hr or 14 hrs prior to CPO intoxication) by no treatment or by injection of TBS (buffer only), POPC (2.5 mg/animal), rePON1 (0.4 mg and 0.63 mg/animal), BL-3050 (0.4 mg rePON1/animal), and atropine (20 mg/kg) with 2-PAM (25 mg/kg). Animals were observed closely for clinical signs during the first 24 hours following CPO intoxication.
  2. * - Significant difference (p < 0.05) compared to all control groups using Mann-Whitney test (see Methods and Results and Discussion sections for more details).
  3. 1 - All groups comprised of 8 mice
  4. 2 - Mice were only poisoned by CPO
  5. 3 - Atropine and 2-PAM concentrations were 20 mg/kg and 25 mg/kg, respectively
  6. 4 - Protein estimation amount for rePON1 was 0.4 mg/animal.
  7. 5 - Protein estimation amount for rePON1 was 0.63 mg/animal.